KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Change in Inventory (2020 - 2025)

Moderna (MRNA) has disclosed Change in Inventory for 6 consecutive years, with -$179.0 million as the latest value for Q4 2025.

  • Quarterly Change in Inventory rose 38.49% to -$179.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $34.0 million through Dec 2025, up 140.96% year-over-year, with the annual reading at $34.0 million for FY2025, 140.96% up from the prior year.
  • Change in Inventory for Q4 2025 was -$179.0 million at Moderna, down from $91.0 million in the prior quarter.
  • The five-year high for Change in Inventory was $501.0 million in Q1 2022, with the low at -$1.1 billion in Q4 2022.
  • Average Change in Inventory over 5 years is $5.3 million, with a median of $51.0 million recorded in 2024.
  • The sharpest move saw Change in Inventory skyrocketed 912.77% in 2021, then tumbled 336.97% in 2022.
  • Over 5 years, Change in Inventory stood at $476.0 million in 2021, then crashed by 336.97% to -$1.1 billion in 2022, then soared by 74.73% to -$285.0 million in 2023, then dropped by 2.11% to -$291.0 million in 2024, then soared by 38.49% to -$179.0 million in 2025.
  • According to Business Quant data, Change in Inventory over the past three periods came in at -$179.0 million, $91.0 million, and $114.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.